Kelly Michael bought SPRY
June 25, 2025 · Form 4 insider transaction
Kelly Michael bought 30,000 shares of ARS Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$0.00
Total value
N/A
InsiderKelly Michael
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 25, 2025
Filing dateJune 27, 2025
Shares owned after30,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the option will vest in full on the earlier of June 25, 2026 or the date of the Issuer's 2026 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.